Cost effectiveness in treating ventilator-associated pneumonia.
Ventilator-associated pneumonia is a common illness in intensive care unit patients. The costs of management are increased when infection involves resistant organisms, as well as unnecessary and prolonged therapy. Efforts at accurate diagnosis, therapy and prevention can reduce the cost impact of this illness.
Niederman
M S
MS
Division of Pulmonary and Critical Care Medicine, Winthrop-University Hospital, Mineola, New York, USA. mniederman@winthrop.org
D000900:Anti-Bacterial Agents / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D003428:Cross Infection / Q000175:diagnosis / Q000191:economics / Q000628:therapy*; D006801:Humans; D007362:Intensive Care Units; D011014:Pneumonia / Q000175:diagnosis / Q000191:economics / Q000628:therapy*; D012121:Respiration, Artificial / Q000191:economics*
D000900:Anti-Bacterial Agents